Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
11/22/1995 | EP0585380B1 Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives |
11/22/1995 | CN1112122A Sulfated-glycolipid derivatives as cell adhesion inhibitors |
11/22/1995 | CN1112112A New bicyclic derivatives of imidazole, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them |
11/21/1995 | US5468879 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
11/21/1995 | US5468764 Administering to a mammal an azole derivative |
11/21/1995 | US5468757 For treating stroke or myocardial infarction in humans |
11/21/1995 | CA2149854A1 Substituted furoxanes |
11/21/1995 | CA1337604C Phospholipid complexes of extract of vitis vinifera, their preparation process and pharmaceutical and cosmetic compositions containing them |
11/16/1995 | WO1995030900A1 MODULATORS OF CYTOKINES OF THE TGF-β SUPERFAMILY AND METHODS FOR ASSAYING FOR SAME |
11/16/1995 | WO1995030675A1 Biphenylcarboxamides useful as 5-ht1d antagonists |
11/16/1995 | WO1995030641A1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities |
11/16/1995 | WO1995030640A1 Substituted fused and bridged bicyclic compounds as therapeutic agents |
11/16/1995 | WO1995030433A1 A novel brain endothelial cell protein and methods for its use |
11/16/1995 | WO1995030424A1 O-desulfated heparin derivatives, methods of making and uses thereof |
11/16/1995 | WO1995030415A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
11/16/1995 | WO1995028418A3 Tachykinin antagonists |
11/16/1995 | DE4416769A1 Effervescent medicament comprising isosorbide-5-mono:nitrate |
11/16/1995 | CA2190027A1 A novel brain endothelial cell protein and methods for its use |
11/16/1995 | CA2189340A1 Modulators of cytokines of the tgf-.beta. superfamily and methods for assaying for same |
11/16/1995 | CA2189336A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
11/16/1995 | CA2189038A1 O-desulfated heparin derivatives, methods of making and uses thereof |
11/15/1995 | EP0682028A1 5,6-Dihydro-4H-thieno 3,4-C pyrroleerivatives, their preparation and their therapeutic use |
11/15/1995 | EP0682021A1 Benzimidazoles, medicines containing them and process for their preparation |
11/15/1995 | EP0682017A1 Substituted bicycle heteroaroylguanidines, their preparation and their application in medicaments and diagnostic agents |
11/15/1995 | EP0682016A1 Pyridine derivatives |
11/15/1995 | EP0682015A1 Piperidine derivates and anti-platelet agents containing the same |
11/15/1995 | EP0682009A2 Intermediate compounds for preparing endothelin-receptor antagonist triterpene derivatives |
11/15/1995 | EP0681840A1 Use of phosphate diester for the treatment of retinal diseases |
11/15/1995 | EP0681836A1 Methods for inhibiting aortal smooth muscle cell proliferation and restenosis with 1,1,2-triphenylbut-1-ene derivatives |
11/15/1995 | EP0681833A2 Nasally administrable compositions |
11/15/1995 | EP0681589A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
11/15/1995 | EP0681582A1 Pyrazole derivatives and pharmaceutical compositions thereof |
11/15/1995 | EP0681569A1 Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
11/15/1995 | EP0491864B1 Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
11/15/1995 | EP0238545B1 C20 through c26 amino steroids |
11/15/1995 | CN1111907A Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
11/15/1995 | CN1111631A Neue 3-phenylsulfonyl-3,7-diazabicyclo|3,3,1¨nonan-verbindungen enthaltende arzneimittel |
11/15/1995 | CN1111630A Adhesion receptor antagonists |
11/15/1995 | CN1111618A Urea-subtituted benzoylguanidines, proces for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them |
11/15/1995 | CN1111508A Fatty acid derivatives |
11/15/1995 | CN1030251C Substituted 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives |
11/14/1995 | US5466826 Process for preparing a physical form of pharmaceutical agent |
11/14/1995 | US5466815 Antilipemic agents |
11/14/1995 | US5466699 (S)-N,N-dimethyl-2-(5-(2-oxo-1,3-oxazolidin -4-ylmethyl)-1H-indole-3-yl)ethylamine; zolmitriptan |
11/14/1995 | US5466698 Substituted tetrahydrophyridines and hydroxypiperidines as central nervous system agents |
11/14/1995 | US5466596 Genetic engineering |
11/14/1995 | CA1337565C Procyanidol oligomeric fractions, the processes for the preparation thereof and pharmaceutical compositions containing them |
11/14/1995 | CA1337548C Fatty acid composition |
11/12/1995 | CA2149092A1 Methods for inhibiting aortal smooth muscle cell proliferation and restenosis with 1,1,2-triphenylbut-1-ene-derivatives |
11/11/1995 | CA2148880A1 5,6-dihydro-4h-thieno[3,4-c]pyrrole derivatives; process for preparing the same and their use as therapeutic agents |
11/11/1995 | CA2147587A1 Method and composition for prophylaxis and treatment of retinal diseases |
11/09/1995 | WO1995029694A1 Collagen hydrolysis accelerator |
11/09/1995 | WO1995029682A1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWIS?a¿ |
11/09/1995 | WO1995029675A1 Method and composition for treating renal disease and failure |
11/09/1995 | WO1995025548A3 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives |
11/09/1995 | CA2189070A1 Method and composition for treating renal disease and failure |
11/09/1995 | CA2189013A1 Binding of e-selectin, p-selectin or l-selectin to sialyl-lewisx or sialyl-lewisa |
11/08/1995 | EP0680761A1 Topical medicament having cicatrizing activity |
11/08/1995 | EP0680755A1 Method for treating inflammation, ischemia-induced cell damage and muscular dystrophy |
11/08/1995 | EP0680489A1 Foldback triplex-forming oligonucleotides |
11/08/1995 | EP0680488A1 2,6-diaminopurine derivatives |
11/08/1995 | EP0680472A1 4,5-diphenylimidazole derivatives, their preparation and their use as acyl coenzyme a: cholesterol-0-acyl-transferase (acat) inhibitor |
11/08/1995 | EP0680469A1 Aminoacid derivates, medicaments containing these compounds and process for preparing the same |
11/08/1995 | EP0539448B1 Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using |
11/08/1995 | CN1111247A Protein kinase C inhibitors |
11/08/1995 | CN1111238A Amino substituted benzosulfonylurea and-thiorea, preparation and pharmaceutical use of same |
11/08/1995 | CN1111158A Products containing G-CSF and TNF binding protein |
11/07/1995 | US5464935 Peptide inhibitors of selectin binding |
11/07/1995 | US5464863 Anticholesterol agents |
11/07/1995 | US5464861 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
11/07/1995 | US5464859 Benzospiroalkene derivatives |
11/07/1995 | US5464858 Hypotensive |
11/07/1995 | US5464788 Tocolytic oxytocin receptor antagonists |
11/07/1995 | US5464615 Use of transglutaminases as immunosuppressants |
11/06/1995 | CA2148666A1 Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them |
11/02/1995 | WO1995029242A1 Angiostatin and method of use for inhibition of angiogenesis |
11/02/1995 | WO1995029172A1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes |
11/02/1995 | WO1995029152A1 Benzamide derivatives as vasopressin antagonists |
11/02/1995 | WO1995029148A1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them |
11/02/1995 | WO1995028947A1 Permeabilizer peptides for increasing blood-ocular barrier permeability |
11/02/1995 | EP0679645A1 Pharmacologically active CNS pyridmidin compounds |
11/02/1995 | EP0679630A1 Bicyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses |
11/02/1995 | EP0679396A1 Use of 3-substituted-2-oxidole-1-carboxamides for the manufacture of a medicament in the treatment and prevention of ischemia induced myocardial injury and cytokine mediated myocardial injury |
11/02/1995 | DE19515401A1 [1,3-·1··4·C¶2¶]-Glycerin-nitrate und Verfahren zu deren Herstellung sowie diese enthaltende Lösungen [1,3 ·· · 1 · 4 C¶2¶] -glycerol-nitrate and methods for their preparation and to solutions containing |
11/02/1995 | CA2187459A1 Permeabilizer peptides for increasing blood-ocular barrier permeability |
11/01/1995 | CN1110921A Navel medicine bag for treatment of hypertension and cerebral arteriosclerosis and its prepn. |
10/31/1995 | US5463107 Useful in prophylaxis and treatment of diseases caused by excessive secretion of endothelin |
10/31/1995 | US5463087 Substituted derivatives of deoxymyoinositol, process for their preparation and their use in medicaments |
10/31/1995 | US5463083 2,5-diaryl tetrahydrothiophenes, tetrahydrofurans and 1,3-diaryl-cyclopentanes which act as platelet activating factor receptor antagonists and/or inhibitors of the enzyme 5-lipoxygenase |
10/31/1995 | US5462965 Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases |
10/31/1995 | US5462959 4-aryl-imidazole derivatives |
10/31/1995 | US5462946 Metal-independent nitroxide or oxazolidine-1-oxyl forming compound in biologically acceptable carrier to protect biological material from oxidative stress |
10/31/1995 | US5462941 1-(cyclohexylalkylamino)-4-(phenyl, thienyl, or furyl) phthalazines; anti-platelet agglutination agents for treatment or prevention of cerebro- or cardiovascular disorders |
10/31/1995 | US5462940 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents |
10/31/1995 | US5462937 Methods for inhibiting vascular smooth muscle cell proliferation and restinosis |
10/31/1995 | US5462936 Administering for treatment of hypertension and ischemic diseases |
10/31/1995 | US5462925 Transforming growth factor β2,3 |
10/31/1995 | US5462752 Inhibition of platelet binding |
10/31/1995 | CA2030421C Agent for treatment of cerebrovascular contraction |
10/31/1995 | CA2012194C Solid pharmaceutical composition containing nifedipine |